Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection

Journal of General Virology

Volumn 95, Issue , 2014, Pages 2757-2768

  Veyer, David L ^a,b,c   de Motes, Carlos Maluquer ^a,d,e   Sumner, Rebecca P ^a,d,f   Ludwig, Louisa ^a   Smith, Geoffrey L ^a,d,g   Johnson, Benjamin F ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SURREY   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g BIOMED CENTRAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; GOLGI ANTI APOPTOTIC PROTEIN; LENTIVIRUS VECTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN B13; VIRUS PROTEIN F1; VIRUS PROTEIN N1;

APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOBLOTTING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; U2OS CELL LINE; VACCINIA; VACCINIA VIRUS; VIRUS ISOLATION; VIRUS STRAIN; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OSTEOSARCOMA; TUMOR CELL LINE;

APOPTOSIS; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HUMANS; OSTEOSARCOMA; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 84910677694     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.068833-0     Document Type: Article

References (65)

1. Alcamí, A., Khanna, A., Paul, N. L. & Smith, G. L. (1999). Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol 80, 949-959.
2. Ali, A. N., Turner, P. C., Brooks, M. A. & Moyer, R. W. (1994). The SPI-1 gene of rabbitpox virus determines host range and is required for hemorrhagic pock formation. Virology 202, 305-314.
3. Aoyagi, M., Zhai, D., Jin, C., Aleshin, A. E., Stec, B., Reed, J. C. & Liddington, R. C. (2007). Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci 16, 118-124.
4. Banadyga, L., Veugelers, K., Campbell, S. & Barry, M. (2009). The fowlpox virus BCL-2 homologue, FPV039, interacts with activated Bax and a discrete subset of BH3-only proteins to inhibit apoptosis. J Virol 83, 7085-7098.
5. Bartlett, N., Symons, J. A., Tscharke, D. C. & Smith, G. L. (2002). The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol 83, 1965-1976.
6. Brooks, M. A., Ali, A. N., Turner, P. C. & Moyer, R. W. (1995). A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J Virol 69, 7688-7698.
7. Carrara, G., Saraiva, N., Gubser, C., Johnson, B. F. & Smith, G. L. (2012). Six-transmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor-containing motif (TMBIM) family. J Biol Chem 287, 15896-15905.
8. Chen, R. A., Jacobs, N. & Smith, G. L. (2006). Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol 87, 1451-1458.
9. Chen, R. A., Ryzhakov, G., Cooray, S., Randow, F. & Smith, G. L. (2008). Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog 4, e22.
10. Cho, Y. S., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M. & Chan, F. K. (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123.
11. Cooray, S., Bahar, M. W., Abrescia, N. G., McVey, C. E., Bartlett, N. W., Chen, R. A., Stuart, D. I., Grimes, J. M. & Smith, G. L. (2007). Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 88, 1656-1666.
12. Dai, P., Wang, W., Cao, H., Avogadri, F., Dai, L., Drexler, I., Joyce, J. A., Li, X. D., Chen, Z. & other authors (2014). Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway. PLoS Pathog 10, e1003989.
13. de Mattia, F., Gubser, C., van Dommelen, M. M., Visch, H. J., Distelmaier, F., Postigo, A., Luyten, T., Parys, J. B., de Smedt, H. & other authors (2009). Human Golgi antiapoptotic protein modulates intracellular calcium fluxes. Mol Biol Cell 20, 3638-3645.
14. DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A. & Marshall, W. L. (2004). Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 279, 36570-36578.
15. Dobbelstein, M. & Shenk, T. (1996). Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J Virol 70, 6479-6485.
16. Doceul, V., Hollinshead, M., van der Linden, L. & Smith, G. L. (2010). Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327, 873-876.
17. Ember, S. W., Ren, H., Ferguson, B. J. & Smith, G. L. (2012). Vaccinia virus protein C4 inhibits NF-kB activation and promotes virus virulence. J Gen Virol 93, 2098-2108.
18. Enari, M., Hug, H. & Nagata, S. (1995). Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78-81.
19. Falkner, F. G. & Moss, B. (1990). Transient dominant selection of recombinant vaccinia viruses. J Virol 64, 3108-3111.
20. Ferguson, B. J., Benfield, C. T., Ren, H., Lee, V. H., Frazer, G. L., Strnadova, P., Sumner, R. P. & Smith, G. L. (2013). Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol 94, 2070-2081.
21. García, M. A., Guerra, S., Gil, J., Jimenez, V. & Esteban, M. (2002). Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene 21, 8379-8387.
22. Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W. & Thornberry, N. A. (1998). Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 273, 32608-32613.
23. Gerlic, M., Faustin, B., Postigo, A., Yu, E. C., Proell, M., Gombosuren, N., Krajewska, M., Flynn, R., Croft, M. & other authors (2013). Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc Natl Acad Sci U S A 110, 7808-7813.
24. Gloeckner, C. J., Boldt, K., Schumacher, A., Roepman, R. & Ueffing, M. (2007). A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7, 4228-4234.
25. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P. & Paoletti, E. (1990). The complete DNA sequence of vaccinia virus. Virology 179, 247-266.
26. Graham, S. C., Bahar, M. W., Cooray, S., Chen, R. A., Whalen, D. M., Abrescia, N. G., Alderton, D., Owens, R. J., Stuart, D. I. & other authors (2008). Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog 4, e1000128.
27. Griffith, T. S. & Ferguson, T. A. (2011). Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 35, 456-466.
28. Gubser, C. & Smith, G. L. (2002). The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol 83, 855-872.
29. Gubser, C., Hué, S., Kellam, P. & Smith, G. L. (2004). Poxvirus genomes: a phylogenetic analysis. J Gen Virol 85, 105-117.
30. Gubser, C., Bergamaschi, D., Hollinshead, M., Lu, X., van Kuppeveld, F. J. & Smith, G. L. (2007). A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog 3, e17.
31. Han, J., Zhong, C. Q. & Zhang, D. W. (2011). Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol 12, 1143-1149.
32. Heinkelein, M., Pilz, S. & Jassoy, C. (1996). Inhibition of CD95 (Fas/ Apo1)-mediated apoptosis by vaccinia virus WR. Clin Exp Immunol 103, 8-14.
33. Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J. L., Schneider, P., Seed, B. & Tschopp, J. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1, 489-495.
34. Hughes, S. J., Johnston, L. H., de Carlos, A. & Smith, G. L. (1991). Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem 266, 20103-20109.
35. Kettle, S., Blake, N. W., Law, K. M. & Smith, G. L. (1995). Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode Mr 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 206, 136-147.
36. Kettle, S., Alcamí, A., Khanna, A., Ehret, R., Jassoy, C. & Smith, G. L. (1997). Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1betaconverting enzyme and protects virus-infected cells from TNF-and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol 78, 677-685.
37. Kibler, K. V., Shors, T., Perkins, K. B., Zeman, C. C., Banaszak, M. P., Biesterfeldt, J., Langland, J. O. & Jacobs, B. L. (1997). Doublestranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J Virol 71, 1992-2003.
38. Kotwal, G. J. & Moss, B. (1989). Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J Virol 63, 600-606.
39. Kvansakul, M., Yang, H., Fairlie, W. D., Czabotar, P. E., Fischer, S. F., Perugini, M. A., Huang, D. C. & Colman, P. M. (2008). Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 15, 1564-1571.
40. Lee, S. B. & Esteban, M. (1994). The interferon-induced doublestranded RNA-activated protein kinase induces apoptosis. Virology 199, 491-496.
41. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Drö ge, W., Krammer, P. H., Fiers, W. & Schulze-Osthoff, K. (1995). Requirement of an ICE/CED-3 protease for Fas/ APO-1-mediated apoptosis. Nature 375, 81-83.
42. Mackett, M., Smith, G. L. & Moss, B. (1984). General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49, 857-864.
43. Maluquer de Motes, C., Cooray, S., Ren, H., Almeida, G. M. F., McGourty, K., Bahar, M. W., Stuart, D. I., Grimes, J. M., Graham, S. C. & Smith, G. L. (2011). Inhibition of apoptosis and NF-kB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog 7, e1002430.
44. Mansur, D. S., Maluquer de Motes, C., Unterholzner, L., Sumner, R. P., Ferguson, B. J., Ren, H., Strnadova, P., Bowie, A. G. & Smith, G. L. (2013). Poxvirus targeting of E3 ligase b-TrCP by molecular mimicry: a mechanism to inhibit NF-kB activation and promote immune evasion and virulence. PLoS Pathog 9, e1003183.
45. Miura, M., Friedlander, R. M. & Yuan, J. (1995). Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci U S A 92, 8318-8322.
46. Perkus, M. E., Goebel, S. J., Davis, S. W., Johnson, G. P., Norton, E. K. & Paoletti, E. (1991). Deletion of 55 open reading frames from the termini of vaccinia virus. Virology 180, 406-410.
47. Postigo, A. & Way, M. (2012). The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors. J Virol 86, 203-213.
48. Postigo, A., Cross, J. R., Downward, J. & Way, M. (2006). Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ 13, 1651-1662.
49. Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S. & Pickup, D. J. (1992). Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69, 597-604.
50. Saraiva, N., Prole, D. L., Carrara, G., Johnson, B. F., Taylor, C. W., Parsons, M. & Smith, G. L. (2013a). hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2. J Cell Biol 202, 699-713.
51. Saraiva, N., Prole, D. L., Carrara, G., Maluquer de Motes, C., Johnson, B. F., Byrne, B., Taylor, C. W. & Smith, G. L. (2013b). Human and viral Golgi anti-apoptotic proteins (GAAPs) oligomerize via different mechanisms and monomeric GAAP inhibits apoptosis and modulates calcium. J Biol Chem 288, 13057-13067.
52. Shisler, J. L. & Moss, B. (2001). Immunology 102 at poxvirus U: avoiding apoptosis. Semin Immunol 13, 67-72.
53. Skaletskaya, A., Bartle, L. M., Chittenden, T., McCormick, A. L., Mocarski, E. S. & Goldmacher, V. S. (2001). A cytomegalovirusencoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A 98, 7829-7834.
54. Smith, G. L., de Carlos, A. & Chan, Y. S. (1989a). Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping. Nucleic Acids Res 17, 7581-7590.
55. Smith, G. L., Howard, S. T. & Chan, Y. S. (1989b). Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. J Gen Virol 70, 2333-2343.
56. Smith, G. L., Chan, Y. S. & Howard, S. T. (1991). Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J Gen Virol 72, 1349-1376.
57. Smith, G. L., Benfield, C. T., Maluquer de Motes, C., Mazzon, M., Ember, S. W., Ferguson, B. J. & Sumner, R. P. (2013). Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 94, 2367-2392.
58. Tait, S. W. & Green, D. R. (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621-632.
59. Taylor, J. M. & Barry, M. (2006). Near death experiences: poxvirus regulation of apoptotic death. Virology 344, 139-150.
60. Tengelsen, L. A., Slabaugh, M. B., Bibler, J. K. & Hruby, D. E. (1988). Nucleotide sequence and molecular genetic analysis of the large subunit of ribonucleotide reductase encoded by vaccinia virus. Virology 164, 121-131.
61. Tewari, M. & Dixit, V. M. (1995). Fas-and tumor necrosis factorinduced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270, 3255-3260.
62. Unterholzner, L., Sumner, R. P., Baran, M., Ren, H., Mansur, D. S., Bourke, N. M., Randow, F., Smith, G. L. & Bowie, A. G. (2011). Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 7, e1002247.
63. Wasilenko, S. T., Meyers, A. F., Vander Helm, K. & Barry, M. (2001). Vaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition pore. J Virol 75, 11437-11448.
64. Wasilenko, S. T., Stewart, T. L., Meyers, A. F. & Barry, M. (2003). Vaccinia virus encodes a previously uncharacterized mitochondrialassociated inhibitor of apoptosis. Proc Natl Acad Sci U S A 100, 14345-14350.
65. Wasilenko, S. T., Banadyga, L., Bond, D. & Barry, M. (2005). The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol 79, 14031-14043.